CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues - Yu, Xiaobing; Munoz-Sagredo, Leonel; Streule, Karolin; Muschong, Patricia; Bayer, Elisabeth; Walter, Romina J.; Gutjahr, Julia C.; Greil, Richard; Concha, Miguel L.; Müller-Tidow, Carsten; Hartmann, Tanja N.; Orian-Rousseau, Véronique (Blood, 2021)
Gesehen am 24.11.2021